Bristol Myers Squibb logo
Bristol Myers Squibb · Life sciences

Director, Global Pricing and Market Access Strategy Lead - Immunology

Bristol Myers Squibb Princeton, NJ Posted Nov 17, 2026
Location
Princeton, NJ
Workplace
On-site / per employer
Posted
Nov 17, 2026

At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits.

This is work that transforms the lives of patients, and the careers of those who do it.

Summary

An exciting opportunity to lead the global pricing and market access strategy for admilparant, a potential first-in-class treatment for IPF and PPF. With positive Phase 3 ALOFT-IPF results and regulatory submissions ahead, this is a highly visible role at an important point in the asset’s journey, shaping access strategy, evidence generation and key development and commercialization decisions.

The Director, Pricing and Market Access Strategy Lead (PASL) for Immunology will lead the Global Market Access (GMAx) strategy for admilparant across international markets. This is a highly visible role with the opportunity to shape how Bristol Myers Squibb positions a priority immunology asset for access success as it moves toward potential launch.

Admilparant is a potential first-in-class, orally administered lysophosphatidic acid receptor 1 (LPA1) antagonist in development for idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF). This is an exciting time to join the team. Following positive Phase 3 ALOFT-IPF results in October 2026, admilparant is moving toward regulatory submissions, with another important milestone ahead as topline results from the fully enrolled ALOFT-PPF trial are expected in early 2027.

Reporting to the Executive Director, GMAx Global Launch Strategy for Cardiovascular and Immunology, the successful candidate will play a central role in shaping the global strategy and bringing an integrated Market Access perspective to key development and commercialization decisions. As the Market Access representative on the Global Product Team, you will work closely with colleagues across Commercial, Medical, Regulatory, Clinical, Advocacy, Policy, Business Insights and Analytics, and markets worldwide. You will also have an active voice in market access and pricing governance, helping navigate the strategic choices that will shape access to admilparant around the world.

We are looking for someone who combines deep global pricing and market access expertise with strong strategic judgement and the ability to bring clarity to complex decisions. They will be comfortable working with and influencing senior leaders, collaborating across functions and geographies, and leading inclusively in a dynamic and increasingly complex access environment.

Responsibilities

  • ✓Lead the integrated Global Market Access strategy for admilparant, working in close partnership with HEOR to develop differentiated payer value propositions across clinical, humanistic and economic dimensions.
  • ✓Shape the evidence-generation strategy for admilparant, ensuring that interventional, non-interventional and real-world evidence addresses the needs of payers, HTA bodies and other access decision-makers.
  • ✓Bring a strong Market Access perspective to the Global Product Team, influencing development and commercialization decisions and helping ensure that clinical trial designs, endpoints and evidence plans support future access and reimbursement.
  • ✓Partner with HEOR and Regulatory to identify opportunities for an optimal product label and relevant patient-reported outcome claims that strengthen the payer value proposition and support the long-term value of the asset.
  • ✓Translate pricing, reimbursement, policy and competitive developments into clear strategic implications for admilparant, working with Business Insights and Analytics, markets and other partners to anticipate changes in the access environment.
  • ✓Embed access and pricing considerations into global brand and commercialization strategy, ensuring that strategic choices reflect payer and HTA requirements across key geographies.
  • ✓Lead the Global Market Access Core Value Team for admilparant, creating alignment across functions and markets on strategy, priorities and execution.
  • ✓Drive the delivery of critical Market Access projects and milestones, aligning cross-functional partners, resolving dependencies and ensuring that decisions and deliverables remain focused on launch readiness and access success.
  • ✓Contribute actively to Market Access and pricing governance, bringing forward clear recommendations and helping senior stakeholders navigate complex strategic trade-offs.

Qualifications

  • ✓An undergraduate degree. An MBA, MPH, MSc, PhD or other relevant advanced degree is preferred but not required.
  • ✓Significant experience in global market access, pricing, reimbursement and/or HEOR within the pharmaceutical or biotechnology industry, ideally including responsibility for global strategy.
  • ✓Strong knowledge of the global access environment and the ability to translate evolving payer, HTA, pricing, reimbursement and policy developments into clear implications for product strategy.
  • ✓Experience shaping access strategy for assets in development or preparing for launch. Experience in immunology, respiratory disease, pulmonary fibrosis or another specialty area would be an advantage, but is not essential.
  • ✓A strong understanding of pharmaceutical development and commercialization, including the ability to assess clinical trial designs, endpoints and evidence plans from a payer and HTA perspective.
  • ✓Experience developing payer value propositions and evidence strategies that integrate clinical, humanistic and economic value.
  • ✓Strong strategic judgement and business and financial acumen, with a demonstrated ability to synthesize complex evidence and differing perspectives into clear recommendations.
  • ✓Demonstrated ability to communicate complex access issues clearly and credibly to senior leaders and cross-functional stakeholders, including audiences without deep market access expertise.
  • ✓A record of leading through influence in a global matrix, building alignment across functions and markets while constructively challenging assumptions when needed.
  • ✓Proven ability to prioritize and deliver multiple complex projects in a fast-moving environment, including situations involving ambiguity or incomplete information.
  • ✓An inclusive and collaborative leadership style, with the cultural awareness needed to work effectively across countries, functions and perspectives.
  • ✓The ability to travel internationally for congresses, market engagements and internal meetings, as required.
  • ✓A consistent demonstration of BMS Behaviors: Integrity, Inclusion, Accountability, Innovation, Passion and Speed.

#LI-Hybrid

We hire for skills and capabilities, not just credentials – if this role excites you, but doesn’t perfectly match your resume, we encourage you to apply anyway.

Compensation Overview

Princeton - NJ - US: $196,390 - $237,982

Originally posted by Bristol Myers Squibb. View original posting